Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis [Phase 2]
Phase 2 trial update for a drug targeting seasonal allergic rhinitis, completed.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis [Phase 4]
Phase 4 trial evaluating nasal budesonide efficacy on nasal nitric oxide in children with allergic rhinitis has completed.
-
FDA approval · 2017-12-29FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HCL — Original Application (Dr. Reddys Laboratories Limited)
FDA approved an original ANDA for guaifenesin and pseudoephedrine hydrochloride tablets from Dr. Reddys Laboratories Limited, establishing a…
-
FDA approval · 2017-12-27FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for levocetirizine dihydrochloride (Vensun Pharmaceuticals, Inc.) under an ANDA. This action maintai…
-
FDA approval · 2017-12-22FDA Approved: CURIST ALLERGY RELIEF — Original Application (Little Pharma, Inc.)
FDA approves CURIST ALLERGY RELIEF through an original ANDA for cetirizine hydrochloride, authorizing the generic for allergy symptom relief…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma [Phase 3]
Phase 3 trial evaluating the immunologic effects and safety of a 60-day course of ALK HDM Sublingual Immunotherapy Tablets in adults with ho…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis [Phase 4]
Phase 4 trial update showing that nebulized beclometasone dipropionate improves nasal patency in children with allergic rhinitis.
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: The Efficacy and Safety of Cettum for Perennial Allergic Rhinitis [NA]
This document notes an update on a clinical trial evaluating the efficacy and safety of Cettum for perennial allergic rhinitis, but the tria…
-
FDA approval · 2017-11-09FDA Approved: CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY — Original Application (Wal-Mart Stores Inc)
FDA approved a generic version of fexofenadine hydrochloride for pediatric allergy uses under an Original Application with Wal-Mart Stores I…
-
FDA approval · 2017-10-30FDA Approved: FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Aurohealth LLC)
FDA approved Aurohealth LLC’s original ANDA for a combination tablet containing fexofenadine hydrochloride and pseudoephedrine hydrochloride…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Tolerability of SLIT With LAIS® Mites Allergoid Tablets
This document provides an update on the tolerability of sublingual immunotherapy with LAIS Mites Allergoid Tablets for allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season
An app-based study assessing symptoms in patients with allergic rhinitis during the pollen season has completed.
-
FDA approval · 2017-10-20FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Selder, S.A. de C.V.)
FDA approved a supplemental application for Fluticasone Propionate nasal spray by Selder for allergy relief.
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites [Phase 1]
Phase 1 trial evaluating a depot-formulated subcutaneous immunotherapy for house dust mite–sensitized allergic rhinitis has completed.
-
FDA approval · 2017-10-17FDA Approved: BUDESONIDE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for Budesonide submitted by Padagis US LLC, expanding regulatory authorization for the product. The …
-
FDA approval · 2017-10-12FDA Approved: MOMETASONE FUROATE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for mometasone furoate.
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial comparing ginger extract to loratadine for efficacy and safety in allergic rhinitis has completed. The study assess…
-
FDA approval · 2017-09-18FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental ANDA for levocetirizine dihydrochloride from Teva Pharmaceuticals USA, Inc., expanding the availability of a gen…
-
FDA approval · 2017-09-18FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Levocetirizine dihydrochloride by Macleods Pharmaceuticals Limited under ANDA205564.
-
FDA approval · 2017-09-15FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (7-eleven)
FDA approved a supplemental application for fexofenadine hydrochloride (ANDA 202039) submitted by 7-eleven.
-
FDA approval · 2017-08-31FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Marlex Pharmaceuticals Inc)
FDA approved a supplemental application for levocetirizine dihydrochloride from Marlex Pharmaceuticals, updating an existing approved produc…
-
FDA approval · 2017-08-31FDA Approved: CHILDRENS FLONASE ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Children's Flonase Allergy Relief (fluticasone propionate) submitted by Haleon US Holdings LLC.
-
FDA approval · 2017-08-29FDA Approved: PROMETHAZINE AND PHENYLEPHRINE HCL, AND CODEINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for a generic combination product containing promethazine, phenylephrine, and codeine phosphate manu…
-
FDA approval · 2017-08-28FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's azelastine hydrochloride as a generic product under an original ANDA.
-
FDA approval · 2017-08-23FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) to expand the label for allergy relie…